CHU DE NICE has a total of 18 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets medical technology, measurement and organic fine chemistry are RESPIRATORY CLINICAL TRIALS LTD, OVUTIME INC and SPIROSURE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | China | 2 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | Canada | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Measurement | |
#3 | Organic fine chemistry | |
#4 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Diagnosis and surgery | |
#2 | Analysing materials | |
#3 | Implantable devices | |
#4 | Heterocyclic compounds | |
#5 | Syringes | |
#6 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Sejor Eric | 6 |
#2 | Dolla Guillaume | 5 |
#3 | Polski Barbara | 5 |
#4 | Esnault Vincent Louis Marie | 5 |
#5 | Rosello Olivier | 5 |
#6 | Lambeau Gerard Jean Frantz | 3 |
#7 | Lambeau Gérard Jean Frantz | 2 |
#8 | Passeron Thierry | 1 |
#9 | Martin Anthony | 1 |
#10 | Dao Pascal | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020070145A1 | Implant system | |
EP3685776A1 | Holding systems for medical instruments | |
EP3685775A1 | Trocar fixing device | |
AU2017294572A1 | 4-anilino-quinoline compounds as anti-cancer agents | |
EP3298969A1 | Surgical suture device | |
EP3320341A1 | Prognosis and monitoring of membranous nephropathy based on the analysis of pla2r1 epitope profile and spreading | |
EP3202338A1 | Anastomotic connector |